{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:18:42Z","timestamp":1790230722901,"version":"4.1.0"},"reference-count":52,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,11,8]],"date-time":"2015-11-08T00:00:00Z","timestamp":1446940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,8]],"date-time":"2015-11-08T00:00:00Z","timestamp":1446940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL085251"],"award-info":[{"award-number":["HL085251"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL073410"],"award-info":[{"award-number":["HL073410"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL085251"],"award-info":[{"award-number":["HL085251"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL068986"],"award-info":[{"award-number":["HL068986"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HL116640"],"award-info":[{"award-number":["K08HL116640"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1002\/pds.3914","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:58:44Z","timestamp":1447030724000},"page":"151-160","source":"Crossref","is-referenced-by-count":9,"title":["Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke"],"prefix":"10.1002","volume":"25","author":[{"given":"James S.","family":"Floyd","sequence":"first","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"},{"name":"Department of Medicine; University of Washington; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri L.","family":"Wiggins","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; University of Washington; Seattle WA USA"},{"name":"Group Health Research Institute; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Longstreth","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; University of Washington; Seattle WA USA"},{"name":"Department of Neurology; University of Washington; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"},{"name":"Department of Epidemiology; University of Washington; Seattle WA USA"},{"name":"Group Health Research Institute; Seattle WA USA"},{"name":"Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs; Office of Research and Development; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"McKnight","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"},{"name":"Department of Biostatistics; University of Washington; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Heckbert","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"},{"name":"Department of Epidemiology; University of Washington; Seattle WA USA"},{"name":"Group Health Research Institute; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; University of Washington; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Psaty","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit; University of Washington; Seattle WA USA"},{"name":"Department of Epidemiology; University of Washington; Seattle WA USA"},{"name":"Department of Medicine; University of Washington; Seattle WA USA"},{"name":"Group Health Research Institute; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,8]]},"reference":[{"issue":"2","key":"10.1002\/pds.3914-BIB0001|pds3914-cit-0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"9733","key":"10.1002\/pds.3914-BIB0002|pds3914-cit-0002","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/pds.3914-BIB0003|pds3914-cit-0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"issue":"10","key":"10.1002\/pds.3914-BIB0004|pds3914-cit-0004","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/dom.12116","article-title":"Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials","volume":"15","author":"Monami","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl","key":"10.1002\/pds.3914-BIB0005|pds3914-cit-0005","first-page":"789","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results","volume":"19","author":"Meinert","year":"1970","journal-title":"Diabetes"},{"issue":"10","key":"10.1002\/pds.3914-BIB0006|pds3914-cit-0006","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/dme.12232","article-title":"Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis","volume":"30","author":"Phung","year":"2013","journal-title":"Diabetic Medicine"},{"issue":"6","key":"10.1002\/pds.3914-BIB0007|pds3914-cit-0007","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/dom.12456","article-title":"Cardiovascular safety of sulphonylureas: over 40\u2009years of continuous controversy without an answer","volume":"17","author":"Abdelmoneim","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"9131","key":"10.1002\/pds.3914-BIB0008|pds3914-cit-0008","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"22","key":"10.1002\/pds.3914-BIB0009|pds3914-cit-0009","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1001\/jama.2014.5951","article-title":"Insulin therapy for type 2 diabetes mellitus","volume":"311","author":"Wallia","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/pds.3914-BIB0010|pds3914-cit-0010","unstructured":"Centers for Disease Control National Diabetes Statistics Report 2014"},{"issue":"5","key":"10.1002\/pds.3914-BIB0011|pds3914-cit-0011","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/dc13-2289","article-title":"Use of antidiabetic drugs in the U.S., 2003-2012","volume":"37","author":"Hampp","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1002\/pds.3914-BIB0012|pds3914-cit-0012","article-title":"Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus","volume":"4","author":"Goudswaard","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/pds.3914-BIB0013|pds3914-cit-0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e1771","article-title":"Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses","volume":"344","author":"Hemmingsen","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/pds.3914-BIB0014|pds3914-cit-0014","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1002\/pds.3914-BIB0015|pds3914-cit-0015","doi-asserted-by":"crossref","first-page":"c103","DOI":"10.1136\/bmj.c103","article-title":"Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study","volume":"340","author":"Boger-Megiddo","year":"2010","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/pds.3914-BIB0016|pds3914-cit-0016","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.1994.00420120047005","article-title":"The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women","volume":"154","author":"Psaty","year":"1994","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1002\/pds.3914-BIB0017|pds3914-cit-0017","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","article-title":"The risk of myocardial infarction associated with antihypertensive drug therapies","volume":"274","author":"Psaty","year":"1995","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/pds.3914-BIB0018|pds3914-cit-0018","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/archinte.1997.00440330066007","article-title":"Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women","volume":"157","author":"Heckbert","year":"1997","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1002\/pds.3914-BIB0019|pds3914-cit-0019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archinte.161.1.37","article-title":"Antihypertensive drug therapies and the risk of ischemic stroke","volume":"161","author":"Klungel","year":"2001","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1002\/pds.3914-BIB0020|pds3914-cit-0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a112220","article-title":"Estimability and estimation in case-referent studies","volume":"103","author":"Miettinen","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.1002\/pds.3914-BIB0021|pds3914-cit-0021","doi-asserted-by":"crossref","DOI":"10.1201\/9781439821862","volume-title":"Analysis of Incomplete Multivariate Data","author":"Schafer","year":"1997"},{"issue":"6","key":"10.1002\/pds.3914-BIB0022|pds3914-cit-0022","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2125.1990.tb03689.x","article-title":"Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects","volume":"29","author":"Kerr","year":"1990","journal-title":"Br J Clin Pharmacol"},{"issue":"8959","key":"10.1002\/pds.3914-BIB0023|pds3914-cit-0023","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(95)91988-0","article-title":"Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme","volume":"345","author":"Herings","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/pds.3914-BIB0024|pds3914-cit-0024","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2307\/2533848","article-title":"Assessing the sensitivity of regression results to unmeasured confounders in observational studies","volume":"54","author":"Lin","year":"1998","journal-title":"Biometrics"},{"issue":"9","key":"10.1002\/pds.3914-BIB0025|pds3914-cit-0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-157-9-201211060-00003","article-title":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study","volume":"157","author":"Roumie","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9131","key":"10.1002\/pds.3914-BIB0026|pds3914-cit-0026","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/pds.3914-BIB0027|pds3914-cit-0027","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/pds.3914-BIB0028|pds3914-cit-0028","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00125-014-3372-z","article-title":"Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study","volume":"58","author":"Mogensen","year":"2015","journal-title":"Diabetologia"},{"issue":"12","key":"10.1002\/pds.3914-BIB0029|pds3914-cit-0029","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jamainternmed.2014.5294","article-title":"Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study","volume":"174","author":"Berkowitz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1002\/pds.3914-BIB0030|pds3914-cit-0030","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s00125-014-3364-z","article-title":"Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations","volume":"57","author":"Patorno","year":"2014","journal-title":"Diabetologia"},{"issue":"3","key":"10.1002\/pds.3914-BIB0031|pds3914-cit-0031","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jamainternmed.2014.6936","article-title":"Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on Food and Drug Administration contraindications","volume":"175","author":"Flory","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1002\/pds.3914-BIB0032|pds3914-cit-0032","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc13-0356","article-title":"Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE)","volume":"36","author":"Nathan","year":"2013","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"10.1002\/pds.3914-BIB0033|pds3914-cit-0033","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.2337\/diabetes.51.2007.S368","article-title":"Sulfonylurea stimulation of insulin secretion","volume":"51","author":"Proks","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1002\/pds.3914-BIB0034|pds3914-cit-0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.90.1.9","article-title":"Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?","volume":"90","author":"Meier","year":"2004","journal-title":"Heart"},{"issue":"4","key":"10.1002\/pds.3914-BIB0035|pds3914-cit-0035","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/01.CIR.86.4.1310","article-title":"Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors","volume":"86","author":"Grover","year":"1992","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/pds.3914-BIB0036|pds3914-cit-0036","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cvr\/27.4.617","article-title":"Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide","volume":"27","author":"Toombs","year":"1993","journal-title":"Cardiovasc Res"},{"issue":"25","key":"10.1002\/pds.3914-BIB0037|pds3914-cit-0037","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1161\/01.CIR.103.25.3111","article-title":"Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide","volume":"103","author":"Mocanu","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/pds.3914-BIB0038|pds3914-cit-0038","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/dc09-2082","article-title":"Hypoglycemia, diabetes, and cardiovascular events","volume":"33","author":"Desouza","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/pds.3914-BIB0039|pds3914-cit-0039","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dmrr.865","article-title":"Vascular disease and diabetes: is hypoglycaemia an aggravating factor?","volume":"24","author":"Wright","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1002\/pds.3914-BIB0040|pds3914-cit-0040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diacare.26.5.1485","article-title":"Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring","volume":"26","author":"Desouza","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1002\/pds.3914-BIB0041|pds3914-cit-0041","doi-asserted-by":"crossref","first-page":"f4533","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ"},{"issue":"15","key":"10.1002\/pds.3914-BIB0042|pds3914-cit-0042","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1002\/pds.3914-BIB0043|pds3914-cit-0043","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.2337\/diacare.28.12.2948","article-title":"Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities","volume":"28","author":"Zammitt","year":"2005","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1002\/pds.3914-BIB0044|pds3914-cit-0044","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1464-5491.2001.00620.x","article-title":"Symptoms of hypoglycaemia in people with diabetes","volume":"18","author":"McAulay","year":"2001","journal-title":"Diabetic Medicine"},{"issue":"6","key":"10.1002\/pds.3914-BIB0045|pds3914-cit-0045","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"Kooy","year":"2009","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1002\/pds.3914-BIB0046|pds3914-cit-0046","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"issue":"7436","key":"10.1002\/pds.3914-BIB0047|pds3914-cit-0047","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"issue":"7506","key":"10.1002\/pds.3914-BIB0048|pds3914-cit-0048","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1002\/pds.3914-BIB0049|pds3914-cit-0049","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1002\/pds.3914-BIB0050|pds3914-cit-0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2002-26705","article-title":"Metformin improves cardiac functional recovery after ischemia in rats","volume":"34","author":"Legtenberg","year":"2002","journal-title":"Hormone and metabolic research\u2009=\u2009Hormon- und Stoffwechselforschung\u2009=\u2009Hormones et metabolisme"},{"issue":"1","key":"10.1002\/pds.3914-BIB0051|pds3914-cit-0051","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1291\/hypres.26.107","article-title":"Cardioprotection by metformin is abolished by a nitric oxide synthase inhibitor in ischemic rabbit hearts","volume":"26","author":"Kawabata","year":"2003","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1002\/pds.3914-BIB0052|pds3914-cit-0052","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jss.2014.05.005","article-title":"Metformin mitigates apoptosis in ischemic myocardium","volume":"192","author":"Elmadhun","year":"2014","journal-title":"J Surg Res"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3914","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3914","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3914\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:25:54Z","timestamp":1625354754000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3914"}},"subtitle":["Oral DM Drugs with Insulin and MI\/Stroke Risk"],"short-title":[],"issued":{"date-parts":[[2015,11,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3914","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,8]]}}}